India
· Delayed Price · Currency is INR Alkem Laboratories Statistics
Total Valuation
Alkem Laboratories has a market cap or net worth of INR 754.45 billion. The enterprise value is 729.96 billion.
| Market Cap | 754.45B |
| Enterprise Value | 729.96B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
| Earnings Date | Nov 11, 2024 |
| Ex-Dividend Date | Aug 9, 2024 |
Share Statistics
Alkem Laboratories has 119.57 million shares outstanding. The number of shares has decreased by -0.02% in one year.
| Shares Outstanding | 119.57M |
| Shares Change (YoY) | -0.02% |
| Shares Change (QoQ) | -0.02% |
| Owned by Insiders (%) | 46.48% |
| Owned by Institutions (%) | 24.20% |
| Float | 31.56M |
Valuation Ratios
The trailing PE ratio is 36.73 and the forward PE ratio is 33.08. Alkem Laboratories's PEG ratio is 2.21.
| PE Ratio | 36.73 |
| Forward PE | 33.08 |
| PS Ratio | 5.93 |
| PB Ratio | 7.32 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.21 |
Enterprise Valuation
| EV / Earnings | 35.53 |
| EV / Sales | 5.73 |
| EV / EBITDA | 29.65 |
| EV / EBIT | 33.50 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 13.24 |
| Debt / EBITDA | 0.58 |
| Debt / FCF | n/a |
| Interest Coverage | 27.33 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 11.86% |
| Revenue Per Employee | 7.30M |
| Profits Per Employee | 1.18M |
| Employee Count | 17,432 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.63% in the last 52 weeks. The beta is 0.42, so Alkem Laboratories's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | +72.63% |
| 50-Day Moving Average | 5,490.22 |
| 200-Day Moving Average | 5,122.58 |
| Relative Strength Index (RSI) | 78.95 |
| Average Volume (20 Days) | 340,298 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alkem Laboratories had revenue of INR 127.32 billion and earned 20.54 billion in profits. Earnings per share was 171.81.
| Revenue | 127.32B |
| Gross Profit | 77.90B |
| Operating Income | 21.79B |
| Pretax Income | 22.90B |
| Net Income | 20.54B |
| EBITDA | 24.36B |
| EBIT | 21.79B |
| Earnings Per Share (EPS) | 171.81 |
Balance Sheet
The company has 42.70 billion in cash and 14.18 billion in debt, giving a net cash position of 28.51 billion or 238.47 per share.
| Cash & Cash Equivalents | 42.70B |
| Total Debt | 14.18B |
| Net Cash | 28.51B |
| Net Cash Per Share | 238.47 |
| Equity (Book Value) | 107.14B |
| Book Value Per Share | 862.46 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 61.19%, with operating and profit margins of 17.11% and 16.13%.
| Gross Margin | 61.19% |
| Operating Margin | 17.11% |
| Pretax Margin | 17.98% |
| Profit Margin | 16.13% |
| EBITDA Margin | 19.13% |
| EBIT Margin | 17.11% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 40.00, which amounts to a dividend yield of 0.63%.
| Dividend Per Share | 40.00 |
| Dividend Yield | 0.63% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 0.02% |
| Shareholder Yield | 0.65% |
| Earnings Yield | 2.72% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |